Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study
Yazar
Castelain, Bernard
Oner, FD
Landmann, C
Ozsahin, Mahmut
Knobel, David
Zouhair, Abderrahim
Tsang, Richard W
Poortmans, Philip
Belkacemi, Y
Bolla, Michel
Üst veri
Tüm öğe kaydını gösterÖzet
Background: Solitary plasmacytoma (SP) of the bone is a rare plasma-cell neoplasm. There are no conclusive data in the literature on the optimal radiation therapy (RT) dose in SP. Therefore, in this large retrospective study, we wanted to assess the outcome, prognostic factors, and the optimal RT dose in patients with SP.
Koleksiyonlar
- Makale [92796]